Levi & Korsinsky Notifies Neumora Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NMRA
Portfolio Pulse from
Law firm Levi & Korsinsky has initiated a class action lawsuit against Neumora Therapeutics regarding potential misrepresentations in their clinical trial data for Navacaprant, a therapeutic candidate for Major Depressive Disorder (MDD). The lawsuit alleges that the company made false statements about trial inclusion criteria, statistical analysis, and data adequacy for the KOASTAL-1 study.
March 21, 2025 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Class action lawsuit claims potential misrepresentation of clinical trial data, which could negatively impact investor confidence and stock performance.
The lawsuit directly targets Neumora Therapeutics and alleges significant misrepresentations in their clinical trial data, which could erode investor trust and potentially impact stock valuation.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100